Copyright Reports & Markets. All rights reserved.

Global and United States Estradiol Transdermal Patches Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Estradiol Transdermal Patches Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Estradiol Transdermal Patches Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Estradiol Transdermal Patches Market Size Growth Rate by Type
    • 1.4.2 25 mg/day
    • 1.4.3 50 mg/day
    • 1.4.4 75 mg/day
    • 1.4.5 100 mg/day
  • 1.5 Market by Application
    • 1.5.1 Global Estradiol Transdermal Patches Market Size Growth Rate by Application
    • 1.5.2 Male
    • 1.5.3 Female
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Estradiol Transdermal Patches Market Size, Estimates and Forecasts
    • 2.1.1 Global Estradiol Transdermal Patches Revenue 2015-2026
    • 2.1.2 Global Estradiol Transdermal Patches Sales 2015-2026
  • 2.2 Global Estradiol Transdermal Patches, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Estradiol Transdermal Patches Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Estradiol Transdermal Patches Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Estradiol Transdermal Patches Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Estradiol Transdermal Patches Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Estradiol Transdermal Patches Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Estradiol Transdermal Patches Revenue Forecast by Region (2021-2026)

3 Global Estradiol Transdermal Patches Competitor Landscape by Players

  • 3.1 Global Top Estradiol Transdermal Patches Sales by Manufacturers
    • 3.1.1 Global Estradiol Transdermal Patches Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Estradiol Transdermal Patches Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Estradiol Transdermal Patches Manufacturers by Revenue
    • 3.2.1 Global Estradiol Transdermal Patches Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Estradiol Transdermal Patches Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Estradiol Transdermal Patches Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Estradiol Transdermal Patches Revenue in 2019
    • 3.2.5 Global Estradiol Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Estradiol Transdermal Patches Price by Manufacturers
  • 3.4 Global Estradiol Transdermal Patches Manufacturing Base Distribution, Product Types
    • 3.4.1 Estradiol Transdermal Patches Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Estradiol Transdermal Patches Product Type
    • 3.4.3 Date of International Manufacturers Enter into Estradiol Transdermal Patches Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Estradiol Transdermal Patches Market Size by Type (2015-2020)
    • 4.1.1 Global Estradiol Transdermal Patches Sales by Type (2015-2020)
    • 4.1.2 Global Estradiol Transdermal Patches Revenue by Type (2015-2020)
    • 4.1.3 Estradiol Transdermal Patches Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Estradiol Transdermal Patches Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Estradiol Transdermal Patches Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Estradiol Transdermal Patches Revenue Forecast by Type (2021-2026)
    • 4.2.3 Estradiol Transdermal Patches Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Estradiol Transdermal Patches Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Estradiol Transdermal Patches Market Size by Application (2015-2020)
    • 5.1.1 Global Estradiol Transdermal Patches Sales by Application (2015-2020)
    • 5.1.2 Global Estradiol Transdermal Patches Revenue by Application (2015-2020)
    • 5.1.3 Estradiol Transdermal Patches Price by Application (2015-2020)
  • 5.2 Estradiol Transdermal Patches Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Estradiol Transdermal Patches Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Estradiol Transdermal Patches Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Estradiol Transdermal Patches Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Estradiol Transdermal Patches Market Size YoY Growth 2015-2026
    • 6.1.1 United States Estradiol Transdermal Patches Sales YoY Growth 2015-2026
    • 6.1.2 United States Estradiol Transdermal Patches Revenue YoY Growth 2015-2026
    • 6.1.3 United States Estradiol Transdermal Patches Market Share in Global Market 2015-2026
  • 6.2 United States Estradiol Transdermal Patches Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Estradiol Transdermal Patches Players by Sales (2015-2020)
    • 6.2.2 United States Top Estradiol Transdermal Patches Players by Revenue (2015-2020)
  • 6.3 United States Estradiol Transdermal Patches Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Estradiol Transdermal Patches Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Estradiol Transdermal Patches Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Estradiol Transdermal Patches Price by Type (2015-2020)
  • 6.4 United States Estradiol Transdermal Patches Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Estradiol Transdermal Patches Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Estradiol Transdermal Patches Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Estradiol Transdermal Patches Price Forecast by Type (2021-2026)
  • 6.5 United States Estradiol Transdermal Patches Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Estradiol Transdermal Patches Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Estradiol Transdermal Patches Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Estradiol Transdermal Patches Price by Application (2015-2020)
  • 6.6 United States Estradiol Transdermal Patches Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Estradiol Transdermal Patches Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Estradiol Transdermal Patches Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Estradiol Transdermal Patches Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Estradiol Transdermal Patches Market Size YoY Growth 2015-2026
  • 7.2 North America Estradiol Transdermal Patches Market Facts & Figures by Country
    • 7.2.1 North America Estradiol Transdermal Patches Sales by Country (2015-2020)
    • 7.2.2 North America Estradiol Transdermal Patches Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Estradiol Transdermal Patches Market Size YoY Growth 2015-2026
  • 8.2 Europe Estradiol Transdermal Patches Market Facts & Figures by Country
    • 8.2.1 Europe Estradiol Transdermal Patches Sales by Country
    • 8.2.2 Europe Estradiol Transdermal Patches Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Estradiol Transdermal Patches Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Estradiol Transdermal Patches Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Estradiol Transdermal Patches Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Estradiol Transdermal Patches Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Estradiol Transdermal Patches Market Size YoY Growth 2015-2026
  • 10.2 Latin America Estradiol Transdermal Patches Market Facts & Figures by Country
    • 10.2.1 Latin America Estradiol Transdermal Patches Sales by Country
    • 10.2.2 Latin America Estradiol Transdermal Patches Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Estradiol Transdermal Patches Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Estradiol Transdermal Patches Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Estradiol Transdermal Patches Sales by Country
    • 11.2.2 Middle East and Africa Estradiol Transdermal Patches Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 UAE

12 Company Profiles

  • 12.1 Novartis
    • 12.1.1 Novartis Corporation Information
    • 12.1.2 Novartis Description and Business Overview
    • 12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Novartis Estradiol Transdermal Patches Products Offered
    • 12.1.5 Novartis Recent Development
  • 12.2 Bayer Healthcare Pharmaceuticals
    • 12.2.1 Bayer Healthcare Pharmaceuticals Corporation Information
    • 12.2.2 Bayer Healthcare Pharmaceuticals Description and Business Overview
    • 12.2.3 Bayer Healthcare Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Bayer Healthcare Pharmaceuticals Estradiol Transdermal Patches Products Offered
    • 12.2.5 Bayer Healthcare Pharmaceuticals Recent Development
  • 12.3 Watson Labs
    • 12.3.1 Watson Labs Corporation Information
    • 12.3.2 Watson Labs Description and Business Overview
    • 12.3.3 Watson Labs Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Watson Labs Estradiol Transdermal Patches Products Offered
    • 12.3.5 Watson Labs Recent Development
  • 12.4 Women First Healthcare Inc
    • 12.4.1 Women First Healthcare Inc Corporation Information
    • 12.4.2 Women First Healthcare Inc Description and Business Overview
    • 12.4.3 Women First Healthcare Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Women First Healthcare Inc Estradiol Transdermal Patches Products Offered
    • 12.4.5 Women First Healthcare Inc Recent Development
  • 12.5 Noven
    • 12.5.1 Noven Corporation Information
    • 12.5.2 Noven Description and Business Overview
    • 12.5.3 Noven Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Noven Estradiol Transdermal Patches Products Offered
    • 12.5.5 Noven Recent Development
  • 12.6 AbbVie
    • 12.6.1 AbbVie Corporation Information
    • 12.6.2 AbbVie Description and Business Overview
    • 12.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 AbbVie Estradiol Transdermal Patches Products Offered
    • 12.6.5 AbbVie Recent Development
  • 12.7 Lumara Health
    • 12.7.1 Lumara Health Corporation Information
    • 12.7.2 Lumara Health Description and Business Overview
    • 12.7.3 Lumara Health Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Lumara Health Estradiol Transdermal Patches Products Offered
    • 12.7.5 Lumara Health Recent Development
  • 12.8 ANI Pharmaceuticals
    • 12.8.1 ANI Pharmaceuticals Corporation Information
    • 12.8.2 ANI Pharmaceuticals Description and Business Overview
    • 12.8.3 ANI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 ANI Pharmaceuticals Estradiol Transdermal Patches Products Offered
    • 12.8.5 ANI Pharmaceuticals Recent Development
  • 12.11 Novartis
    • 12.11.1 Novartis Corporation Information
    • 12.11.2 Novartis Description and Business Overview
    • 12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Novartis Estradiol Transdermal Patches Products Offered
    • 12.11.5 Novartis Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Estradiol Transdermal Patches Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Estradiol Transdermal Patches Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Estradiol Transdermal Patches market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Estradiol Transdermal Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Estradiol Transdermal Patches market is segmented into
    25 mg/day
    50 mg/day
    75 mg/day
    100 mg/day

    Segment by Application, the Estradiol Transdermal Patches market is segmented into
    Male
    Female

    Regional and Country-level Analysis
    The Estradiol Transdermal Patches market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Estradiol Transdermal Patches market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Estradiol Transdermal Patches Market Share Analysis
    Estradiol Transdermal Patches market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Estradiol Transdermal Patches business, the date to enter into the Estradiol Transdermal Patches market, Estradiol Transdermal Patches product introduction, recent developments, etc.
    The major vendors covered:
    Novartis
    Bayer Healthcare Pharmaceuticals
    Watson Labs
    Women First Healthcare Inc
    Noven
    AbbVie
    Lumara Health
    ANI Pharmaceuticals

    Buy now